Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258
2008

Canine Prostate Carcinoma Model Using Cell Line CT1258

Sample size: 19 publication Evidence: moderate

Author Information

Author(s): Melani AM Fork, Hugo Murua Escobar, Jan T Soller, Katharina A Sterenczak, Saskia Willenbrock, Susanne Winkler, Martina Dorsch, Nicola Reimann-Berg, Hans J Hedrich, Jörn Bullerdiek, Ingo Nolte

Primary Institution: University of Veterinary Medicine Hanover

Hypothesis

Is the canine prostate carcinoma cell line CT1258 a suitable model for in vivo testing?

Conclusion

The cell line CT1258 can effectively mimic the behavior of naturally occurring prostate carcinoma in dogs.

Supporting Evidence

  • The CT1258 cell line was derived from a highly malignant canine prostate tumor.
  • Tumors induced in mice resembled the original tumor in growth pattern and histological appearance.
  • The study showed a high Ki67 index, indicating aggressive tumor behavior.

Takeaway

Researchers used a special dog cancer cell line to create tumors in mice, which helped them study how the cancer behaves.

Methodology

The study involved inoculating 19 NOD-Scid mice with the CT1258 cell line and observing tumor growth and behavior.

Potential Biases

The study was descriptive and not primarily focused on statistical significance.

Limitations

Some mice developed thymoma, which may affect the overall health assessment of the study.

Participant Demographics

19 NOD-Scid mice (10 male, 9 female).

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-8-240

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication